Antacids Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Antacids Market
1.1. Definition and Scope
1.1.1. Definition of Antacids
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Antacids Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Antacids Market By Drug Class
1.2.3. Antacids Market By Formulation Type
1.2.4. Antacids Market By Distribution Channel
1.2.5. Antacids Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.1.3. Driver 3
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.2.3. Restraint 3
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.3.3. Opportunity 3
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Antacids Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Antacids Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Antacids Market By Drug Class
5.1. Introduction
5.2. Antacids Revenue By Drug Class
5.2.1. Antacids Revenue (USD Billion) and Forecast, By Drug Class, 2020-2032
5.2.2. Proton Pump Inhibitors
5.2.2.1. Proton Pump Inhibitors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. H2-Receptor Antagonists
5.2.3.1. H2-Receptor Antagonists Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Acid Neutralizers
5.2.4.1. Acid Neutralizers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Antacids Market By Formulation Type
6.1. Introduction
6.2. Antacids Revenue By Formulation Type
6.2.1. Antacids Revenue (USD Billion) and Forecast, By Formulation Type, 2020-2032
6.2.2. Tablet
6.2.2.1. Tablet Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Liquid
6.2.3.1. Liquid Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Powder
6.2.4.1. Powder Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Others
6.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Antacids Market By Distribution Channel
7.1. Introduction
7.2. Antacids Revenue By Distribution Channel
7.2.1. Antacids Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
7.2.2. Retail Pharmacy
7.2.2.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Hospital Pharmacy
7.2.3.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Online Pharmacy
7.2.4.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Antacids Market By Country
8.1. North America Antacids Market Overview
8.2. U.S.
8.2.1. U.S. Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
8.2.2. U.S. Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
8.2.3. U.S. Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.3. Canada
8.3.1. Canada Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
8.3.2. Canada Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
8.3.3. Canada Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Antacids Market By Country
9.1. Europe Antacids Market Overview
9.2. U.K.
9.2.1. U.K. Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.2.2. U.K. Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
9.2.3. U.K. Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Germany
9.3.1. Germany Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.3.2. Germany Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
9.3.3. Germany Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. France
9.4.1. France Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.4.2. France Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
9.4.3. France Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.5. Spain
9.5.1. Spain Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.5.2. Spain Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
9.5.3. Spain Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.6.2. Rest of Europe Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
9.6.3. Rest of Europe Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Antacids Market By Country
10.1. Asia Pacific Antacids Market Overview
10.2. China
10.2.1. China Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.2.2. China Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
10.2.3. China Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Japan
10.3.1. Japan Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.3.2. Japan Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
10.3.3. Japan Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. India
10.4.1. India Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.4.2. India Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
10.4.3. India Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Australia
10.5.1. Australia Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.5.2. Australia Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
10.5.3. Australia Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.6. South Korea
10.6.1. South Korea Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.6.2. South Korea Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
10.6.3. South Korea Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.7.2. Rest of Asia-Pacific Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
10.7.3. Rest of Asia-Pacific Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Antacids Market By Country
11.1. Latin America Antacids Market Overview
11.2. Brazil
11.2.1. Brazil Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.2.2. Brazil Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
11.2.3. Brazil Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. Mexico
11.3.1. Mexico Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.3.2. Mexico Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
11.3.3. Mexico Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.4.2. Rest of Latin America Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
11.4.3. Rest of Latin America Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Antacids Market By Country
12.1. Middle East & Africa Antacids Market Overview
12.2. GCC
12.2.1. GCC Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.2.2. GCC Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
12.2.3. GCC Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.3. South Africa
12.3.1. South Africa Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.3.2. South Africa Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
12.3.3. South Africa Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Antacids Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.4.2. Rest of Middle East & Africa Antacids Revenue (USD Billion) and Forecast By Formulation Type, 2020-2032
12.4.3. Rest of Middle East & Africa Antacids Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Antacids Market
13.1. Antacids Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Antacids Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Sun Pharmaceuticals Ltd
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2023
14.1.3.2. Sun Pharmaceuticals Ltd. 2023 Antacids Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Reckitt Benckiser Group plc
14.3. GlaxoSmithKline plc
14.4. Pfizer Inc.
14.5. Bayer AG
14.6. Sanofi
14.7. BoehringerIngelheim International GmbH
14.8. Dr. Reddy’s Laboratories Ltd.
14.9. Procter & Gamble
14.10. Takeda Pharmaceutical Company Limited
Frequently Asked Questions
How big is the antacids market?
The Antacids market size was valued at USD 7.2 billion in 2023.
What is the CAGR of the global antacids market from 2024 to 2032?
The CAGR of Antacids is 4.8% during the analysis period of 2024 to 2032.
Which are the key players in the antacids market?
The key players operating in the global market are including Sun Pharmaceuticals Ltd, Reckitt Benckiser Group plc, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Sanofi, BoehringerIngelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Procter & Gamble and Takeda Pharmaceutical Company Limited
Which region dominated the global antacids market share?
North America held the dominating position in Antacids industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of Antacids during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global antacids industry?
The current trends and dynamics in the antacids industry include increasing prevalence of gastrointestinal disorders, rising consumption of processed and fast foods, and growing awareness about digestive health.
Which Drug Class held the maximum share in 2023?
The proton pump inhibitors drug class held the maximum share of the antacids industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
